Literature DB >> 10621974

Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

B E Clausen1, C Burkhardt, W Reith, R Renkawitz, I Förster.   

Abstract

Conditional mutagenesis in mice has recently been made possible through the combination of gene targeting techniques and site-directed mutagenesis, using the bacteriophage P1-derived Cre/loxP recombination system. The versatility of this approach depends on the availability of mouse mutants in which the recombinase Cre is expressed in the appropriate cell lineages or tissues. Here we report the generation of mice that express Cre in myeloid cells due to targeted insertion of the cre cDNA into their endogenous M lysozyme locus. In double mutant mice harboring both the LysMcre allele and one of two different loxP-flanked target genes tested, a deletion efficiency of 83-98% was determined in mature macrophages and near 100% in granulocytes. Partial deletion (16%) could be detected in CD11c+ splenic dendritic cells which are closely related to the monocyte/macrophage lineage. In contrast, no significant deletion was observed in tail DNA or purified T and B cells. Taken together, LysMcre mice allow for both specific and highly efficient Cre-mediated deletion of loxP-flanked target genes in myeloid cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10621974     DOI: 10.1023/a:1008942828960

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  46 in total

1.  B lymphocyte-specific, Cre-mediated mutagenesis in mice.

Authors:  R C Rickert; J Roes; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

2.  Recent origin of the P lysozyme gene in mice.

Authors:  G A Cortopassi; A C Wilson
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

3.  Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.

Authors:  W F Pickl; O Majdic; P Kohl; J Stöckl; E Riedl; C Scheinecker; C Bello-Fernandez; W Knapp
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

4.  Targeted oncogene activation by site-specific recombination in transgenic mice.

Authors:  M Lakso; B Sauer; B Mosinger; E J Lee; R W Manning; S H Yu; K L Mulder; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

5.  Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor.

Authors:  C Scheicher; M Mehlig; R Zecher; K Reske
Journal:  J Immunol Methods       Date:  1992-10-02       Impact factor: 2.303

6.  Mouse lysozyme M gene: isolation, characterization, and expression studies.

Authors:  M Cross; I Mangelsdorf; A Wedel; R Renkawitz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

Review 7.  Advances in gene targeting methods.

Authors:  R Kühn; F Schwenk
Journal:  Curr Opin Immunol       Date:  1997-04       Impact factor: 7.486

8.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors.

Authors:  H Karasuyama; F Melchers
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

9.  Tissue specific and position independent expression of the complete gene domain for chicken lysozyme in transgenic mice.

Authors:  C Bonifer; M Vidal; F Grosveld; A E Sippel
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

10.  Repetitive sequence involvement in the duplication and divergence of mouse lysozyme genes.

Authors:  M Cross; R Renkawitz
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

View more
  1066 in total

1.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

2.  Cutting edge: microRNA regulation of macrophage fusion into multinucleated giant cells.

Authors:  James R Sissons; Jacques J Peschon; Frank Schmitz; Rosa Suen; Mark Gilchrist; Alan Aderem
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

3.  Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia.

Authors:  Juraj Bies; Marek Sramko; Joanna Fares; Michael Rosu-Myles; Steven Zhang; Richard Koller; Linda Wolff
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

4.  TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation.

Authors:  Alessia Perino; Thijs Willem Hendrik Pols; Mitsunori Nomura; Sokrates Stein; Roberto Pellicciari; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

5.  Role of myeloid-specific G-protein coupled receptor kinase-2 in sepsis.

Authors:  Sitaram Parvataneni; Babu Gonipeta; Nandakumar Packiriswamy; Taehyung Lee; Haritha Durairaj; Narayanan Parameswaran
Journal:  Int J Clin Exp Med       Date:  2011-11-09

6.  Macrophage-Associated Lipin-1 Enzymatic Activity Contributes to Modified Low-Density Lipoprotein-Induced Proinflammatory Signaling and Atherosclerosis.

Authors:  Aimee E Vozenilek; Aaron R Navratil; Jonette M Green; David T Coleman; Cassidy M R Blackburn; Alexandra C Finney; Brenna H Pearson; Roman Chrast; Brian N Finck; Ronald L Klein; A Wayne Orr; Matthew D Woolard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-12-07       Impact factor: 8.311

7.  Association of Increased F4/80high Macrophages With Suppression of Serum-Transfer Arthritis in Mice With Reduced FLIP in Myeloid Cells.

Authors:  Qi-Quan Huang; Robert Birkett; Renee E Doyle; G Kenneth Haines; Harris Perlman; Bo Shi; Philip Homan; Lianping Xing; Richard M Pope
Journal:  Arthritis Rheumatol       Date:  2017-08-01       Impact factor: 10.995

8.  Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication.

Authors:  Larissa B Thackray; Erning Duan; Helen M Lazear; Amal Kambal; Robert D Schreiber; Michael S Diamond; Herbert W Virgin
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

9.  LYN- and AIRE-mediated tolerance checkpoint defects synergize to trigger organ-specific autoimmunity.

Authors:  Irina Proekt; Corey N Miller; Marion Jeanne; Kayla J Fasano; James J Moon; Clifford A Lowell; Douglas B Gould; Mark S Anderson; Anthony L DeFranco
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

10.  Alternatively Activated Macrophages Revisited: New Insights into the Regulation of Immunity, Inflammation and Metabolic Function following Parasite Infection.

Authors:  Jessica C Jang; Meera G Nair
Journal:  Curr Immunol Rev       Date:  2013-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.